Sanofi Net Worth is$103.3 B
VN:F [1.9.22_1171]
deserves the money?
Rating: 0.0/5 (0 votes cast)
VN:F [1.9.22_1171]
Would you date ?
Rating: 0.0/5 (0 votes cast)
Company Name: Sanofi S.A.

Company Type: S.A. (corporation)

Traded As: SAN, SNY, 0I42, SNW

Foundation: 20 August 2004 (by acquisition)

Location: 54, rue La Boétie, 8th arrondissement of Paris, Paris, France

Key People: Chris Viehbacher (chief executive officer), Serge Weinberg (Chairman)

Industry: Pharmaceutical industrys

Products: Prescription drug and over-the-counter drugs for thrombosis, cardiovascular disease, diabetes, central nervous system disorders, oncology and internal medicine, vaccines (#Products)

Revenue: Euro33.38 billion (2011)
Operating Income: €7.499 billion (2011)
Net Income: €5.693 billion (2011)
Assets: €100.16 billion (2011)
Equity: €56.38 billion (2011)
Num Employees: 113,719 (2011)
Subsid: Genzyme, Sanofi Pasteur, Chattem, Shantha Biotechnics, Zentiva, Medley (company), Nichi-Iko

Homepage: http://www.sanofi.com/

Intl: yes

Sanofi S.A. is a French multinational pharmaceutical company headquartered in Paris, France, the world's fourth-largest by prescription sales. Sanofi engages in the research and development, manufacturing and marketing of pharmaceutical products for sale principally in the prescription market, but the firm also develops over-the-counter medication. The company covers 7 major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis and vaccines (it is the world's largest producer of the latter through its subsidiary Sanofi Pasteur). Sanofi is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA). The company was formed as Sanofi-Aventis in 2004 by the merger of Aventis and Sanofi-SynthA(C)labo. It changed its name to Sanofi in May 2011. In January 2012 Sanofi announced that they will invest $125 Million in Warp Drive Bio to support their cancer research program.
Sanofi-SynthA(C)labo was formed in 1999 when Sanofi (former subsidiary of Total) merged with SynthA(C)labo (former subsidiary of L'OrA(C)al). The merged company was based in Paris, France.
Aventis was formed in 1999 when French company RhA?ne-Poulenc S.A. merged with the German corporation Hoechst Marion Roussel, which itself was formed from the 1995 merger of Hoechst AG with Roussel Uclaf and Marion Merrell Dow. The merged company was based in Schiltigheim, near Strasbourg, France.
Sanofi-Aventis was formed in 2004 when Sanofi-SynthA(C)labo acquired Aventis. In early 2004, Sanofi-SynthA(C)labo made a hostile takeover bid worth a??47.8 billion for Aventis. Initially, Aventis rejected the bid because it felt that the bid offered inferior value based on the company's share value. The three-month takeover battle concluded when Sanofi-SynthA(C)labo launched a friendly bid of a??54.5 billion in place of the previously rejected hostile bid. French government intervention also played an active role. The French gover

Sanofi Latest News

Sanofi tip ends in $465M settlement between Mylan and DOJ

Despite the criticism and calls for the government to get a better deal out of Mylan, the drugmaker announced on Thursday that it finalized a settlement with the Department of Justice for $465 million relating to EpiPen’s misclassification on Medicaid.
Posted: August 17, 2017, 2:17 pm

Sanofi Shows Improved Relative Price Performance; Still Shy Of Benchmark

In a welcome move, Sanofi (SNY) saw its Relative Strength Rating improve from 68 to 72 on Friday. XAutoplay: On | Off IBD's unique rating identifies market leadership with a 1 (worst) to 99 (best) score. The grade shows how a stock's price movement over ...
Posted: August 18, 2017, 12:00 pm

Sanofi’s Revenue Growth in 2Q17

Success! has been added to your Ticker Alerts. Subscriptions can be managed in your user profile. The above chart shows Sanofi’s segment-wise revenue over the last few quarters. In 2016, Sanofi reorganized itself into five business units: Sanofi Genzyme ...
Posted: August 16, 2017, 1:44 am

Sanofi : Mylan Agrees to Pay $465 Million to Resolve False Claims Act Liability

BOSTON, Aug. 17-- The Acting U.S. Attorney for the District of Massachusetts, William D. Weinreb, issued the following news release: Congress enacted the Medicaid Drug Rebate Program to ensure that state Medicaid programs were not susceptible to price ...
Posted: August 19, 2017, 2:47 am

Sanofi-Aventis awarded $38 million for blowing whistle on EpiPen maker

Big Pharma Sanofi-Aventis was awarded $38.7 million Thursday as its share of a $465 million False Claims Act settlement by Mylan for knowingly misclassifying EpiPen as a generic drug to avoid paying rebates owed to Medicaid. Mylan Inc. and Mylan Specialty ...
Posted: August 18, 2017, 5:48 am
Related Topics:
How Much Is Sanofi Earnings, How Much Is Sanofi Income, How Much Is Sanofi Net Worth, How Much Is Sanofi Salary, How Much Is Sanofi Worth, Sanofi, Sanofi Age, Sanofi Aventis, Sanofi Aventis Headquarters, Sanofi Aventis Products, Sanofi Bio, Sanofi Biosurgery, Sanofi Careers, Sanofi Country, Sanofi Date Of Birth, Sanofi Diabetes, Sanofi Dividend, Sanofi Earnings, Sanofi Ethnicity, Sanofi Forest Park Ga, Sanofi Genzyme, Sanofi Gossips, Sanofi Group, Sanofi Height, Sanofi History, Sanofi Home Town, Sanofi Images, Sanofi Income, Sanofi Job, Sanofi Nationality, Sanofi Net Worth, Sanofi Networth, Sanofi News, Sanofi Oncology, Sanofi Partner, Sanofi Pasteur, Sanofi Pasteur Inc, Sanofi Pasteur Jobs, Sanofi Pasteur Orlando, Sanofi Pasteur Orlando Jobs, Sanofi Patient Assistance, Sanofi Patient Connection, Sanofi Pipeline, Sanofi Place Of Birth, Sanofi Products, Sanofi Rumors, Sanofi Salary, Sanofi Secrets, Sanofi Services, Sanofi Stock, Sanofi Stock Price, Sanofi Videos, Sanofi Weight, Who Is Sanofi,